Are pharma-funded awareness campaigns a blind spot in prescription advertising rules?
Sydney researcher Professor Barbara Mintzes says it's a grey area.
For almost a decade, US men were faced with TV, online ads and billboards about the risks of low testosterone or ‘low T’, as it was branded.
Eventually, in 2014, the Food and Drug Administration (FDA) issued a safety warning about the potential link between testosterone treatment and cardiac events.
